Management of Severely Uncontrolled Diabetes with HbA1c of 14%

Clinical Significance and Diagnosis

An HbA1c of 14% reflects extremely poor glycemic control, representing an average blood glucose of approximately 355 mg/dL over the previous 2-3 months, indicating a high risk for both microvascular and macrovascular complications, according to the American Diabetes Association 1, 2.
This level is significantly above the diagnostic threshold for diabetes (≥6.5%) and indicates a high risk for complications, as stated by the American Diabetes Association 2, 3.

For HbA1c levels ≥10% (especially with values as high as 14%), insulin therapy should be initiated immediately rather than starting with oral agents alone, as recommended by the American College of Physicians 4, 5.
The American College of Physicians suggests beginning with basal insulin (glargine, detemir, or degludec) at 0.1-0.2 units/kg/day, with consideration for adding mealtime insulin if symptoms are severe 5.

The American Diabetes Association recommends assessing for diabetic ketoacidosis (DKA), especially in patients with type 1 diabetes or severely insulin-deficient type 2 diabetes 6.
The American College of Cardiology suggests screening for existing microvascular complications (retinopathy, nephropathy, neuropathy) and macrovascular disease 7.

The American College of Physicians recommends an initial goal to reduce HbA1c to <9% within 3 months to minimize glucose toxicity, and a long-term goal to achieve HbA1c <7% for most patients to prevent microvascular complications 9, 1.
If glycemic targets are not achieved within 3 months, the American College of Physicians suggests intensifying insulin regimen by adjusting basal insulin dose based on fasting glucose levels and adding or increasing mealtime insulin doses based on postprandial glucose levels 5.

The American Diabetes Association advises confirming the HbA1c result is accurate, as certain conditions (anemia, hemoglobinopathies, uremia) can interfere with measurements 10, 2.
The American College of Physicians recommends avoiding overly aggressive glucose lowering that might lead to hypoglycemia, especially in elderly patients or those with cardiovascular disease 9.